Imagion Biosystems Welcomes New Director, Farewells Three

Imagion Biosystems Ltd. (AU:IBX) has released an update.

Imagion Biosystems Ltd., a pioneer in early cancer detection technology, has announced significant changes to its Board of Directors with the appointment of Melanie Leydin as a Non-Executive Director and the impending resignation of three longstanding directors before the next General Meeting. Melanie Leydin brings over two decades of accounting and corporate governance expertise to the team, a move welcomed by Executive Chairman Bob Proulx as the company continues to advance its innovative MagSense® imaging technology for cancer diagnosis.

For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.